The acceleration of the modernization of traditional Chinese medicine may benefit the leading pharmaceutical equipment companies

Traditional Chinese medicine is a national treasure and an important resource, as well as an important part of China's medical system
.
It is of great significance to inherit and develop the cause of traditional Chinese medicine
.
The modernization of traditional Chinese medicine is based on the experience and clinical basis of traditional Chinese medicine, through high-tech modern science and technology, abiding by strict norms and standards, to develop a new generation of traditional Chinese medicine that meets today's needs, so that it can be widely circulated in the application market
.
The epidemic since 2020 has catalyzed the accelerated development of the traditional Chinese medicine industry towards modernization, and the national level has successively issued a series of favorable support policies such as "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics" to vigorously promote the modernization process of traditional Chinese medicine
.
At present, both the number of applications and the approval time of new Chinese medicines have improved.
In 2021, a total of 13 new Chinese medicines have been approved, hitting a new high in the past five years
.
So, how can the traditional Chinese medicine industry move towards modernization better? In addition to policy support, talent team building and scientific research are indispensable
.
In addition, a research report recently released by Caitong Securities pointed out that "medical intelligent manufacturing" is the only way for traditional Chinese medicine to modernize
.
It is understood that traditional Chinese medicines often have certain challenges in quality control and other aspects, but in the pharmaceutical intelligent manufacturing mode, it is conducive to the traceability and control of product quality, the realization of lean manufacturing process of traditional Chinese medicine, and the use of data.
Continuous improvement
.
"Made in China 2025" has pointed out the direction for the transformation and upgrading of the traditional Chinese medicine manufacturing industry, and has become an important measure for the high-quality development of the traditional Chinese medicine industry and serving the "Healthy China" strategy
.
In recent years, traditional Chinese medicine companies such as Buchang Pharmaceutical, China Resources Sanjiu, and Liuyao are closely focusing on the trend of intelligent manufacturing and accelerating their transformation and upgrading to enhance their core competitiveness
.
However, the current domestic Chinese medicine pharmaceutical technology and equipment as a whole are still difficult to match the needs of the high-quality development of the modern Chinese medicine industry.
Most of the Chinese medicine manufacturing industry is at the level of Industry 2.
0, that is, the automation transformation of the production process can be completed.

.
There are not many enterprises that have achieved the level of Industry 3.
0 or 4.
0, the level of informatization and digitization is not high, the overall process and quality control level is still relatively backward, and the system does not have perfect autonomous perception, learning, analysis, decision-making, communication and coordinated control, and Ability to work collaboratively
.
With the support of favorable policies, the modernization of traditional Chinese medicine has accelerated, and the industry will also speed up in the direction of intelligent manufacturing.
The industry expects that this will benefit the upstream pharmaceutical equipment industry
.
At present, many domestic pharmaceutical equipment companies have been actively involved in the transformation of automation, intelligence and informatization, strengthening technical research around the relevant links of traditional Chinese medicine manufacturing, and accelerating the research and development of intelligent, networked, digital and new complete sets that conform to the concept of environmental protection.
Traditional Chinese medicine pharmaceutical equipment, to help the modernization process of traditional Chinese medicine
.
In the face of a new round of opportunities, head companies may benefit significantly compared with small and medium-sized pharmaceutical machine companies
.
Caitong Securities stated in the report that Chutian Technology will benefit from the increase in industry concentration brought about by this round of modernization of traditional Chinese medicine
.
Conclusion With the support of favorable policies, the modernization of traditional Chinese medicine is accelerating.
In the future, with the continuous improvement and improvement of laws and regulations, as well as the continuous efforts of traditional Chinese medicine enterprises and traditional Chinese medicine pharmaceutical equipment enterprises, I believe that the development of traditional Chinese medicine modernization will be further accelerated, and there will be more in the future.
The variety of pharmaceutical companies has entered the international stage
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.